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Abstract
Background: Multiple Sclerosis is a disease of the central nervous system involving a variety of debilitating physical,
sensory, cognitive and emotional symptoms. This literature review evaluated the impact of psychological
interventions on the physiological symptoms associated with the illness.
Methods: A systematic literature search was conducted using Medline, PsycINFO, Scopus, and the Cochrane Library
databases, as well as reference lists. Relevant studies were selected and assessed according to a preset protocol.
Results: The search produced 220 articles, with 22 meeting inclusion criteria for the review. A total of 5,705
subjects with Multiple Sclerosis were analyzed. Results from the included studies indicate a general improvement in
both psychological and physiological outcomes following psychological treatment. The most highly influenced
physical symptoms include fatigue, sleep disturbances, pain, and physical vitality.
Conclusions: Findings from the review suggest a positive relationship between psychological interventions and
physiological Multiple Sclerosis symptoms. Implications for future research are discussed.
Keywords: Multiple sclerosis, Psychological interventions, Physical health outcomes, Mind/body connection
Background
This paper provides a brief literature review concerning
the relationship between physiological difficulties associ-
ated with Multiple Sclerosis (MS) and psychological in-
terventions intended to remediate or otherwise improve
functionality and quality of life. Our specific focus is the
unearthing of evidence that psychological or behavioral
treatments have an impact on both the psychological
well-being and the physiological consequences of the
disease. We are also interested in exploring the relation-
ship between MS symptoms and psychological issues
within the broader framework of the mind-body connec-
tion. The paper summarizes the structure of this frame-
work along with the trends in the literature; presents the
etiology and primary physiological consequences of MS;
a summary of its psychological consequences investi-
gated thus far; and an application of the mind/body
hypothesis in the MS field. We identify some key gaps in
related research and propose potential areas for further
work to address these gaps.
Consciousness and the brain: the mind-body connection
The classic mind-body problem searches for an under-
standing of the distinctions – or lack thereof – between
physical and mental entities: Is the physical brain a
distinct entity from its mental processes? How do we
know, how is it defined, and what implications are there
for how we understand and treat our health?
Conceptions of a dualistic framework follow the early
work of Descartes who proposed that the mind is a non-
physical substance distinct from the brain, that our mind
(and all it encompasses) is different from our physical
brain in its fundamental composition as matter. In con-
trast to that is the argument for materialism proposing
that because the world consists only of matter, there is no
true distinction between the mental and the physical, i.e.,
that all mental states, properties, and processes are
connected and interact with physical states, properties,
and processes. Much of Western culture continues to
preserve a belief in the dichotomy between mind and body.
We see dualism in medical science, which maintains
the notion that disorders stem from either the physical
or the mental, treating the mind and the body separately
[1]. Although there was an appeal that from the field of
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medical specialties [2] for a more comprehensive treat-
ment model (i.e., a bio-psycho-social approach), a strictly
biomedical approach to physical illnesses persists, treat-
ing physical bodily symptoms to the exclusion of mental
health [3]. Findings from more current research suggest
that is changing in several areas, proposing correlations
between consciousness and the brain [4]; that negative
emotions (e.g., depression and anxiety) are highly associ-
ated with the development of coronary heart disease [5];
and that such emotions have a negative effect on cardio-
vascular and immune system responses [6]. Further re-
search suggests that negative emotions can produce
direct and indirect influence on state and trait pain [7]
and fatigue [8]. Similarly, Pressman and Cohen [9] sug-
gest that positive emotions can lead to an improvement
in physical health, such as increased physical functioning
in adults, protection against infectious illness, and lower
mortality rates.
The link between mind and body has been proposed go-
ing back as far as the 1970s, when Ellen Langer conducted
one of the first tests of the mind/body unity theory on
disease and ageing. Langer [10] suggested that a healthy
mind would put the body in a healthier place, forming the
basis for the 1980 “counterclockwise study”,i nw h i c h
Langer and her students studied what effects of turning
back the clock psychologically would have on the physio-
logical states of the participants [11]. The results of this
study changed the way we view not only aging (the cohort
being elderly men) but also of traditional western notions
of “limits” - that biology is not destiny, that “it is not
primarily our physical selves that limit us but rather our
mindset about our physical limits” [10].
Physiology and key psychological consequences of
multiple sclerosis
Multiple Sclerosis is a chronic degenerative disease of
the central nervous system that involves functionality of
the brain and spinal cord, with physical, sensory, cogni-
tive and emotional responses ranging from mild to se-
vere. The relatively high variability in symptomology is
determined primarily by the location of the lesions in
the brain and spinal cord. Lesions in the frontal and par-
ietal lobes result in cognitive and emotional problems;
plaque in the cerebrum, brain stem and spinal cord re-
sult in functional limitations of extremities [12]. In this
sense, MS is a highly individual disease, prompting inter-
ventions targeting broad categories of disease progres-
sion and psychosocial impacts. The National Multiple
Sclerosis Society (NMSS) estimates prevalence of MS in
the United States at 400,000, and global prevalence at
over 2 million people [13].
A diagnosis of MS often has profound social and psycho-
logical consequences. Because MS usually strikes individuals
in their most productive years, its impact can be over-
whelming [14]. The unpredictable and variable nature of
MS also makes it particularly difficult to accept. The newly
diagnosed individual is faced first with the shock of a dis-
ease, which is chronic and unpredictable in its course, often
with progressive impacts on critical spheres of functioning.
The future undoubtedly promises reduced physical function
and disability, along with disruptions in education, employ-
ment, sexual and family functioning, friendships and activ-
ities of daily living. The grim prognosis and the added
unpredictability of day-to-day health in relapse-remitting
MS and side effects of medication greatly impacts upon
q u a l i t yo fl i f e[ 1 5 ] .
Multiple Sclerosis can also have a considerable influence
on the individual’s sense of self [16,17]. Physical changes
and functional limitations may lead to a sense of loss of
identity or role strain especially when the individual can
no longer perform previously valued activities [15]. It is
frequently necessary to redefine one’s self-image in order
to incorporate the limitations imposed by MS. Each time
the individual experiences a new loss of function this
sense of loss may be renewed. One of the major sources of
psychological distress related to the physical impairments
is sexual dysfunction. The most frequent complaints are
erectile and ejaculatory dysfunctions in men, vaginal lubri-
cation in women, and a loss of libido and difficulty in
achieving orgasm in both genders [18]. This problem
covers significant aspects of life and can arise at any time
during the course of MS, with a prevalence that varies
between 50% and 90% [19].
Depressive features are often reported by people who
have MS. Lifetime prevalence of major depressive disorder
(MDD) is approximately 50% [20]. This is three times the
rate reported in the general population [21]; the high
prevalence may have multiple etiologies, including psy-
chosocial factors such as the difficulty to deal with one’s
emotions, and lack of social support [22]. Depression is
one of the main determinants of quality of life and may
further compromise cognitive function, and may lead to
suicidal intent. It often impairs relationships and reduces
compliance with disease- modifying treatments [23]. In
addition, people with MS and MDD have been found to
suffer from high levels of anxiety [24].
Relationship between physiological and psychological
features in multiple sclerosis
Depressive features following the onset of MS physio-
logical symptoms may not be a simple psychological reac-
tion to MS, but instead may be related to biological
aspects of the illness itself [25]. Biological processes such
as inflammation, neuroendocrine dysfunction or regional
brain damage [26] are likely to be at least partly respon-
sible for depressive features.
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symptoms has been underestimated in the past, but
there is growing evidence of increased interest within
the scientific community. For example, a number of pro-
spective studies suggest that psychological stress in-
creases relapse risk in MS [27]. We believe that more
focused investigations into the physiological outcomes of
a psychological intervention may lead to a better under-
standing of therapeutic options for people with MS.
It is also possible that the relationship between the
underlying biological mechanism of MS and depressive
symptoms works in two directions. If that is the case,
successful treatment of depression utilizing behavioral
approaches could also affect the underlying MS physi-
ology, encouraging consideration of psychological inter-
ventions that could reduce the symptomatology of the
illness and moving from a palliative care framework for
behavioral treatments to a potentially therapeutic one.
There is little direct evidence for this hypothesis cur-
rently, primarily because behavioral interventions rarely
include biological markers or even consider symptoms
assessment among the outcomes. Thus far, psychological
outcomes are most often the only ones expected and
assessed at the end of a behavioral treatment [28], with-
out considering the possibility that an intervention could
impact physiological measures.
Methods
This review focuses on psychological interventions for the
treatment of Multiple Sclerosis. A systematic search strat-
egy was conducted with Medline, PsycINFO, Scopus and
the Cochrane Library using the search terms “multiple
sclerosis” in combination with “psychological inter-
vention”, “psychological treatment”, “psychotherapy” or
“psychological therapy”. Further articles were included
from the reference lists of review articles. There were no
time limitations for the bibliographic search, but emphasis
was placed on recent publications, post 2004. The list of
articles provided by database and article reference search
were screened for articles that investigate the effects of
psychological interventions on physical health and symp-
toms of people with MS. Two reviewers independently
assessed articles. Susceptibility to bias was evaluated
following the QUOROM Statements [29]. Only articles
published in English from peer-reviewed journals were
considered. Four criteria were used to select studies: 1)
the study reported either primary or secondary outcomes
on physical health, either self-reported or instrumentally
assessed; 2) the study investigated the effects of a psycho-
logical intervention; 3) the outcomes resulted from a com-
parison between groups, with a randomized controlled
trial; 4) study results referred to a minimum of 10 partici-
pants. Data from the included article were extracted and
reported into an Excel spreadsheet. The review includes
randomized clinical trials, that intrinsically present a risk
of bias. It is therefore expected that results will provide a
reliable recommendation (Evidence Level 1) [30].
Results
Database and article references search provided a list of
220 papers. Twenty-two articles met the criteria for the
inclusion in the review. Included studies and their prop-
erties are reported in Table 1.
Overall, a total of 5,705 subjects with MS were included
in the analysis, with a large study that included 3,623 sub-
jects [38]. Setting aside that study, sample sizes ranged
from 14 to 240 subjects. Most of these studies included
people with MS with a limited physical disability (e.g.,
EDSS <5.5) and with the average disease duration of
8 years and a mean age over 40 years. Articles that were
included describe different psychological interventions for
people with MS including cognitive-behavioral interven-
tions, relaxation training, meditation, and stress manage-
ment and coping skill promotion. There was variability
about the duration of the intervention ranging from a
week to two years, with an average length of two months.
Control groups were composed primarily of subjects on a
waiting-list or by no additional treatment group (usual
care only). Four studies referred to a comparison between
interventions, with controls receiving what was character-
ized as a less efficacious treatment or a gold-standard
comparison.
Psychological variables were primary outcomes in all the
included papers. The impact of the interventions on these
outcomes was generally positive. Overall, psychological
treatments produced an improvement in quality of life
and psychological well-being, reducing depressive symp-
toms, anxiety and perceived stress. Most of the psycho-
logical treatments obtained positive effects. These effects
were emphasized when the comparison was between the
treatment and a usual care or a waiting-list control group.
The majority of the psychological effects on the physical
symptoms were assessed using self-report measures, refer-
encing the perception of physical variables or symptoms
(e.g., fatigue, pain), or the perception of general physical
health. Following the psychological intervention, percep-
tions of general health improved, with higher scores on
the physical subscales on quality of life questionnaires.
One symptom positively affected by psychological treat-
ments is fatigue, in which subjects from experimental
groups often reported a significant decrease in fatigue
along with a subsequent reduction in physical limitations
related to tiredness. Similarly, improvements in sleep
disturbances, physical vitality, and vigor were reported.
Psychological interventions also appeared to reduce the
perception of pain.
Changes in physical issues do not result only from self-
reported questionnaires but few studies investigated these
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Study Patients (n) Severity of
symptoms
Mean disease
duration
Mean
age
Type of intervention Duration of the
intervention
Type of
control
Results on
psychological variables
Results on symptoms
Barlow et al.
[31]
216 N/R 12 years Chronic Disease Self-
Management Course, a
lay-led self-
management
intervention that
provides participants
with a range of skills
and strategies
6 weeks Waiting-list CDSMC had an impact on self-
management self- efficacy and
trends towards improvement
on depression and MS self-
efficacy were noted. All
improvements were maintained
at 12-months
CDSMC had an impact on
MSIS physical status
Stuifbergen
et al.[32]
113 15.65 on the
Incapacity
Status Scale
10.76 years 45,79 lifestyle-change classes
and telephone follow-
up
8 weeks Waiting-list Improvement of self-efficacy,
health-promoting behaviors
and mental health (SF36)
Reduction of Bodily Pain as
measured with the SF36, no
difference on the severity of
impairment as measured with
the Incapacity Status Scale
Ghafari
et al. [33]
66 EDSS <5.5 2 years 31,5 Progressive Muscle
Relaxation Technique
63 sessions
during two
months
No
intervention
One and two months after
intervention the experimental
group reported better QoL
The physical component of
QoL (PCS-8) improved as well
Tesar et al.
[34]
29 EDSS <5.5
(mean 3.2)
5.1 years 38.2 Psychological program
which combines
proven cognitive-
behavioral strategies
for coping with stress
with body exercises
7 weeks Waiting-list The therapy group showed
long-term improvements in
depressive stress coping style
The therapy group showed
short-term improvement in
“vitality and body dynamics”.
Forman &
Lincon [35]
40 23 on the
Guys
Neurological
Disability
Scale
9.8 years 47.5 The intervention group
programme was
designed for people
with multiple sclerosis
and focused on
adjustment to illness.
6 weeks Waiting-list Patients allocated to the group
intervention reported fewer
depressive symptoms than
those in the control group but
there were no significant
differences in anxiety
symptoms, self-efficacy or
quality of life.
No changes on the MS Impact
Scale - Physical
O’Hara et al.
[36]
183 17 (median)
on the Barthel
Index
11.8 years 51.5 The intervention
comprised discussion
of self-care based on
client priorities, using
an information booklet
about self-care.
The discussions
lasted between 1
and 2 hours and
were conducted
on two occasions,
over a one month
period.
No
intervention
At follow-up the intervention
group had better SF-36 health
scores, in mental health and
vitality. Participants in the
intervention group had main-
tained levels of independence
at follow-up while the control
group showed a signicant
decrease in independence
Participants in the intervention
group reported that assistance
with daily activities was less
essential than individuals in
the control group at follow-up;
However, there were no
improvements in
independence in daily living,
mobility or a reduction in the
number of occasions
individuals were assisted with
activities
Baron et al.
[37]
127 22.4 on the
Guys
Neurological
Disability
N/R 48.1 telephone
administered cognitive
behavioral therapy
16 weeks telephone
administered
supportive
emotion-
Improvements in depression
and anxiety
Improvement in insomnia
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Scale; patients
with insomnia
focused
therapy
Tompkins
et al. [38]
3623 N/R 48.9
RM;
43.5
Control
PREP for participant
and partner in
workshop sessions or
teleconference series;
8 hrs programming
(1 or 2 days or 4–6
wks for teleconference)
In person 1–2
days or
teleconference
4–6 weeks
No
intervention
RM improvement with
increased QoL at 3 months
Number of MS symptoms at
baseline not signfiicantly
different at baseline between
groups but comorbidiities did
(with control at fewer),
controled at analysis stage.
Improved communications;
willingness to try; better
prepared for issues; acquisition
of tools to address MS issues
with partner
Khan et al.
[39]
101 EDSS
between 2
and 8; KFS 0-2
10.69 (TR); 9.73
(Control)
49.5
TR;
51.1
Control
Individualised
rehabilitation
programme
12 months waiting-list MSIS and GHQ-28 assessed par-
ticipation and QoL; no differ-
ences between control and
treatment on MSIS physical or
psychological or GHQ subscales
FIM motor scores
improvement at statistically
significant levels for 2 groups.
Sutherland
et al. [40]
22 EDSS < = 5.0;
no prior CB
techniques
for 6 months
prior to study
Diagnosis : 9.36 yrs (TR);
6.45 yrs (Control)
AT program supervised
training
10 weeks No
intervention
HRQOL positively affected;
participants in relaxation less
limited by physical findings but
not for the AT . AT group
positively impacted regarding
role limitations due to
emotional problems.
Pain dimension large effect of
MSQOL indicates AT practice
may associate with diminished
pain perception.; Improved
vigor (POMS); decreased
perception of fatigue
Maguire
[41]
33 N/R N/R 45.13 Relaxation training and
ongoing work with
biologically oriented
imagery.
6 days Standard
care
Imagery group subjects
demonstrated significant
reductions in state anxiety and
significant alteration in their
illness imagery
No significant differences were
found between the two
groups with regard to
decrease in MS symptoms
across time
Mathiowetz
et al. [42]
169 Multiple
Sclerosis
Functional
Composite
score: −.97
15 years 48,8 Energy Conservation
course
6 weeks Waiting-list increase self-efficacy and some
aspects of quality of life
significant effects on reducing
the physical and social
subscales of Fatigue Impact
Scale and on increasing the
Vitality subscale of the SF-36
scores
Grossman
et al. [43]
150 EDSS =3 8.7 years 47.29 A modified version of
the Mindfulness-Based
Stress Reduction
(MBSR)
8 weeks Usual Care improvement on Quality of Life
and other measures of well-
being, for at least 8 months
Improvement on fatigue
Tavee et al.
[44]
17 3,25
(Experimental
group); 2,79
(controls)
10,4
(Experiemental
group); 19,4
(Controls)
48,7 Meditation 2 months Standard
care
General improvement on
mental health
Improvements on pain
perception, phisical health,
fatigue and vitality
Van Kessel
et al. [45]
72 EDSS =3,45 6 years 45 CBT based on a
cognitive behavior
model of fatigue
8 weeks relaxation
training
A significant time effect was
obtained for depression, anxiety
and perceived stress, with both
Both CBT and RT appear to be
clinically effective treatments
for fatigue in MS patients,
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groups. CBT performed better,
on this regard, at the post-
treatment, but not at follow-up
evaluations
although the effects for CBT
are greater than those for RT.
Mohr et al.
[46]
121 EDSS =3,1 7,05 since
diagnosis
42.66 individual stress
management program
20–24 weeks Waiting-list Participants in the
experiemental group reported
lower level of distress
Reduction of brain lesions in
comparison with the control
group (lower number of new
gadolinium-enhancing brain
lesions on MRI)
Mohr et al.
[47]
60 N/R 8.5 years 44,6 individual cognitive
behavioral therapy,
group psychotherapy
16 weeks sertraline Reductions on depression for
each group
treatment for depression is
associated with reductions in
the severity of fatigue
symptoms, and that this
relationship is due primarily to
treatment related changes in
mood
Schwartz
[48]
132 EDSS =4,7 7,9 43 coping skills group 8 weeks peer
telephone
support
coping skills intervention
yielded gains in psychosocial
role performance, coping
behavior, and numerous
aspects of well-being. In
contrast, the peer support
intervention increased external
health locus of control but did
not influence psychosocial role
performance or well-being
No differences between the
two groups on physical
limitations and fatigue
Wassem &
Dudley [49]
27 EDSS =3,36 3,49 44 nursing intervention in
promoting adjustment
and symptom
management
4 weeks Not specified Treatment participants had
significant improvements in
symptom management at the
4-yearfollow up
significant improvements in
sleep and fatigue levels
Lincon et al.
[50]
240 The assessment group received a detailed
cognitive assessment; the treatment group
received the same cognitive assessment
and a treatment programme designed to
help reduce the impact of their cognitive
problems
No
intervention
no effect of the interventions
on mood, quality of life,
subjective cognitive impairment
or independence.
No differences among the
three groups on perceived
health
Mohr et al.
[51]
14 EDSS =3,6 11.3 47.4 individual cognitive
behavioral therapy,
group psychotherapy
16 weeks Sertraline Reductions on depression for
each group
successful treatment of MS
depression (either
pharmacologically or with
psychotherapy) can reduce
IFNg production by OKT3 or
MBP-stimulated immune cells
Kopke et al.
[52]
150 United
Kingdom
Neurological
Disability
Scale =7,9
5,2 38 Patient education
program to enhance
decision autonomy
4 hours Standard
care
The patient education program
led to more autonomous
decision making in patients
with relapsing MS
The number of relapses
reported by subjects in the
experimental group was
considerably lower than the
one from controls
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2changes with objective measurements. Results indicate that
a stress-management intervention reduces the number of
brain lesions associated with the relapsing-remitting process
of MS, with a consequent reduction of crisis [46]. A short
patient education program successfully reduced the number
of relapses, compared to controls [52]. Furthermore, suc-
cessful treatment of depression (either with psychological or
pharmacological interventions) resulted associated with a re-
duction in non-specific and antigen-specific interferon pro-
duction [51].
In general, with the caveat of the limited number of
studies involved, when the psychological intervention lead
to a better psychological outcome, such as the reduction
of depressive symptoms or the improvement in psycho-
logical well-being, the assessed physical outcomes were
positively influenced. A correlation can be observed be-
tween the extent of changes from a psychological perspec-
tive and the size of change in MS symptoms. More
intense and efficacious psychological interventions lead to
higher changes on a physical level than less intense behav-
ioral treatments.
Articles included in the review seldom formally assessed
the level of disability making it impossible to deeply inves-
tigate this aspect of findings. Future studies would benefit
from a greater focus on assessment of disability in terms
of functioning and inclusion of more non-self-report
measures pre and post-intervention.
Discussion
Results from the studies considered in this review suggest
that psychological interventions may well have a positive
effect on MS symptoms. In particular, fatigue, physical vi-
tality, sleep disturbances and pain are the physical vari-
ables investigated that appeared to benefit from such
interventions, together with perception of general health.
Physical changes following a psychological intervention
are reported on both self-report measurements and, in a
more limited number of studies, on biological measures. If
results are limited to questionnaire outcomes, it could be
argued that psychological interventions may not provide
objective changes, but could change the perception of the
physical symptomology. It appears highly likely that both
subjective and objective outcomes are moving toward one
specific direction: that the mind does influence the body,
even effecting MS symptoms. These findings should not
surprise us, as we consider increasing evidence of the
mind’s influence on the body. The idea that psychological
treatments, however, may influence the physical expres-
sion (i.e., symptoms) of the disease itself is relatively new
and few studies dare to explore this idea. In fact, relatively
few papers considered some physical symptoms as a pos-
sible outcome for psychological interventions. Most of
these studies only included a limited self-report assess-
ment of health. It is possible that researchers in the MS
field have thus far not tried to influence the possibility that
interventions at the psychological level can result in posi-
tive effects on the body. Those who assessed physical
changes with objective measures [46,51,52] found interest-
ing results that surely deserve to be deepened and further
explored. Since a cure for the various form of MS is not
yet available, it makes sense to explore every possible
therapeutic option, including the possibility that psycho-
logical treatment need not be palliative or burden-relief in
nature [25,28]. Not surprisingly, fatigue, physical vitality
and sleep disorder are often part of diagnostic criteria in
the framework of depressive disorders. This is consistent
with our hypothesis as an example of the effects that the
mental domain can express over the body.
A few limitations of the present study should be noted.
The majority of the studies included in the review utilized
self-report measures for acquiring physical outcome data.
As self-report measures are inherently based on subjective
perception, the quality of their construct validity may have
confounded the results of the review. Another limitation
was that none of the studies reviewed included outcome
data of any form of disability, possibly narrowing the
scope of our assessment of physical outcomes. Finally, few
studies in total were eligible for review; the studies in-
cluded may therefore not adequately represent the general
MS population.
Conclusions
This brief review investigates the hypothesis that psy-
chological interventions for individuals with multiple
sclerosis have a positive impact not only at the psycho-
logical level, but also on the physical domains, in par-
ticular on symptoms of disease. Despite a paucity of
studies that included assessment of physical variables as
outcomes for psychological interventions, available data
strongly suggest that the hypothesized connection does
exist. In particular, fatigue, pain, physical vitality and
quality of sleep, assessed by subjects’ evaluations,
improve significantly after most of the interventions.
Furthermore, a few cutting edge studies that assessed
physical outcomes with objective measurements suggest
that there are actual physical benefits, for example in
terms of interferon level and brain lesions.
Our results indicate that there is a strong unexplored
potential for psychological interventions to improve the
quality of life of people with MS from both a psycho-
logical perspective and in terms of a reduction in symp-
toms. Given the potential improvement of well-being,
we strongly urge research efforts be applied in this
direction.
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